Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.73% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NKTR · Mar 31, 2024
NEKTAR THERAPEUTICS. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-057312General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-221.30% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
75.04% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
60.56% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-163.72% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
126.66% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
27.73% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.96%
- Current
- 0.73%
- Delta
- -0.23%
- Previous
- -213.72%
- Current
- -221.30%
- Delta
- -7.59%
- Previous
- 17.87%
- Current
- 75.04%
- Delta
- 57.17%
- Previous
- 62.53%
- Current
- 60.56%
- Delta
- -1.97%
- Previous
- -292.59%
- Current
- -163.72%
- Delta
- 128.87%
- Previous
- 126.67%
- Current
- 126.66%
- Delta
- -0.01%
- Previous
- 37.05%
- Current
- 27.73%
- Delta
- -9.32%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NKTR Fundamental State →Has State · NEKTAR THERAPEUTICS →Transitioned To · NKTR Fundamental State →Transitioned To · NKTR CAPEX_INTENSITY_DECREASED →Transitioned To · NKTR CASH_GENERATION_DECREASED →Transitioned To · NKTR INVENTORY_PRESSURE_INCREASED →Transitioned To · NKTR MARGIN_DECREASED →Transitioned To · NKTR PROFITABILITY_INCREASED →Transitioned To · NKTR R_AND_D_INTENSITY_DECREASED →Transitioned To · NKTR SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.